about
Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study[Fresh versus pasteurized yogurt: comparative study of the effects on microbiological and immunological parameters, and gastrointestinal comfort].Capsule endoscopy in patients refusing conventional endoscopy.Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.Role of capsule endoscopy in suspected celiac disease: A European multi-centre study.Capsule endoscopy in the small bowel Crohn's disease.[A high-resolution gastroenterology clinic in Andalusia: what is it, and how should it work]Evolution of the incidence of inflammatory bowel disease in Southern Spain.Guideline for wireless capsule endoscopy in children and adolescents: A consensus document by the SEGHNP (Spanish Society for Pediatric Gastroenterology, Hepatology, and Nutrition) and the SEPD (Spanish Society for Digestive Diseases).Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis.A survey-based analysis on endoscopic quality indicators compliance among Spanish endoscopists.Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients.Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease.Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene.The management of lactose intolerance among primary care physicians and its correlation with management by gastroenterologists: the SEPD-SEMG national survey.Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results.Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey.Accidental intrarectal administration of alcohol enema induces proctocolitis and fecal incontinence.Posterior laryngitis: effects of treatment with omeprazole alone.Is safety infliximb during pregnancy in patients with inflammatory bowel disease?PillCamColon Capsule for the study of colonic pathology in clinical practice. Study of agreement with colonoscopy.Capsule endoscopy in young patients with iron deficiency anaemia and negative bidirectional gastrointestinal endoscopy.Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey.How is inflammatory bowel disease managed in Spanish gastroenterology departments? The results of the GESTIONA-EII survey.Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease.Role of capsule endoscopy in alarm features and non-responsive celiac disease: A European multicenter study.Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.Initial experience with golimumab in clinical practice for ulcerative colitis.Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.Patients' perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in SpainColon capsule endoscopy is a safe and useful tool to assess disease parameters in patients with ulcerative colitisLoss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel diseaseKnowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE surveyInfluence of age, body mass index and comorbidity on major outcomes in acute pancreatitis, a prospective nation-wide multicentre study.Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data.Traumatic lumbosacral meningocele. Case report[Anemia due to appendicular tubulo-villous adenoma.][Utility of capsule endoscopy in pediatric gastroenterology]Screening of hepatocellular carcinoma in autoimmune cirrhosis: more value than costs?
P50
Q28307732-A68D19ED-22AB-4806-8FC9-6EB5FF13487DQ33441618-492F1993-CD76-4EC3-BC75-D00D9EB452E0Q33780186-75DB6C25-09DC-4BE6-A916-22D6D6487033Q33843746-AF5C8B43-D427-4102-847A-64AC59927E2BQ37625232-289BC5CC-62B8-4797-9AA5-828D9D8F04F5Q38205216-924E450F-F1CE-4004-8E00-81F60BFE1249Q38443404-6A6D8F03-39E2-4CA9-A7F8-3FF5F93A3B4CQ38641635-690E01D1-E442-44C9-A26F-95566ABE8660Q38670439-2C083112-A5A1-4347-A39A-9ABD016A2A6EQ38696735-3454C1DA-928A-4F4A-88C5-2DBEBDD79FDFQ38779371-646477B7-328D-41FA-A9AE-3ADC28883B33Q38795236-03F96AE1-2653-4A42-9B10-7E2420EDABDFQ40171515-C8DC424A-F8B7-42CE-9203-BCCC85F9DCC6Q40282145-66E86E8E-2AE5-423F-A968-26F6FF42E438Q40519235-D7B1C8E4-0FE0-462A-9A2F-4EFD4BE8508EQ41428914-3A4A1D26-C14B-4F81-B098-1B1D30770D3BQ42701889-601A6EE3-93A8-4E3C-901B-DC9A96C995EDQ43350411-16086FD8-9E28-478F-957D-B7B3BEDCEB74Q43688043-3A4BCABB-CDDE-4B01-908F-32FCFD777F38Q44107824-EC4A4C48-4E02-43A7-807F-AE797A0A0533Q44940934-3F5AB24B-7EB1-4C32-AF8D-DD9D61915743Q45366384-268A9F73-A2A1-4C49-AECC-591B06E60B9CQ47113533-196EB72B-7468-4643-9FB1-5917AC2D6B01Q47374817-5EA87D2F-1F13-4529-B01F-3D78133DED2EQ47682210-342A4AC0-1AA6-4D9B-B9B0-48CEED83B844Q47858322-872BEC32-70F1-40EC-BD84-A464D5E0585AQ48099543-ECA388EB-B16A-4786-BA73-5D2FFE28EDC5Q48904882-A98E082F-CD1B-44C6-AC1F-BDE9EF74A10AQ53206616-36494071-7749-49F9-8451-9FC3964CD1A3Q53469319-2174D5BC-62AB-43BB-8D63-0CE4D4F3ABBAQ57074031-0F6F9622-962E-4D05-846E-F31D2D766E46Q57109712-41A2C6C8-C1D2-431E-A54A-DBCFFFC0B499Q60302346-7E175D7D-109B-4230-B143-4A5DC014FDD9Q61962888-A13817E5-6F1B-4905-B7CE-B0555B879F22Q64926900-3A6E0C90-2E46-49D0-9D7E-239F86C480BFQ64983137-052F35E9-5963-4EDE-B3F8-7421710FE924Q67557043-AC8E3D7B-D093-49E5-A5F8-4DDAB5E318B4Q73258636-CA6364F2-3415-41A4-A813-AAEC2EAACC6AQ79322429-1E48E695-FE90-43BA-8010-D48526F48F83Q80559034-D1E405F6-7098-4212-8E58-8905EE9F774F
P50
description
researcher ORCID ID = 0000-0003-3646-8919
@en
name
Federico Argüelles-Arias
@ast
Federico Argüelles-Arias
@en
Federico Argüelles-Arias
@es
Federico Argüelles-Arias
@nl
type
label
Federico Argüelles-Arias
@ast
Federico Argüelles-Arias
@en
Federico Argüelles-Arias
@es
Federico Argüelles-Arias
@nl
prefLabel
Federico Argüelles-Arias
@ast
Federico Argüelles-Arias
@en
Federico Argüelles-Arias
@es
Federico Argüelles-Arias
@nl
P1153
22936826500
P21
P31
P496
0000-0003-3646-8919